Reprint—Comprehensive Foot Examination and Risk Assessment: A Report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, With Endorsement by the American Association of Clinical Endocrinologists

Boulton, Andrew J.M.; Armstrong, David G.; Albert, Stephen F.; Frykberg, Robert G.; Hellman, Richard; Kirkman, M. Sue; Lavery, Lawrence A.; LeMaster, Joseph W.; Mills, Joseph L.; Mueller, Michael J.; Sheehan, Peter; Wukich, Dane K.

doi:10.1093/ptj/88.11.1436

Cited by 133 publications

(147 citation statements)

References 0 publications

Supporting

Mentioning

129

Contrasting

Unclassified

Order By: Relevance

“…An evidence-based screening test battery of 45 individual items and tools was proposed to address all body systems. 4,15–45 Information on the test battery items is provided in Tables 2 and 3.…”

Section: Resultsmentioning

confidence: 99%

Feasibility of population screening tests to establish a healthy ageing trajectory

et al. 2019

View full text Add to dashboard Cite

Objectives:There are no agreed comprehensive tests for age-related changes to physical, emotional, mental and social functioning. Research into declining function focuses on those 75 years and older and little is known about age-related changes in younger people. The aims of this project were (1) to ascertain a comprehensive test battery that could underpin community-based health screening programmes for people aged 40–75 years and pilot both (2) community-based recruitment and (3) the utility, acceptability, response burden and logistics.Methods:A total of 11 databases were searched using a broad range of relevant terms. An identified comprehensive, recent, high-quality systematic review of screening instruments for detection of early functional decline for community-dwelling older people identified many relevant tools; however, not all body systems were addressed. Therefore, lower hierarchy papers identified in the rapid review were included and expert panel consultation was conducted before the final test battery was agreed. Broad networks were developed in one Australian city to aid pilot recruitment of community-dwellers 40–75 years. Recruitment and testing processes were validated using feasibility testing with 12 volunteers.Results:The test battery captured (1) online self-reports of demographics, health status, sleep quality, distress, diet, physical activity, oral health, frailty and continence; and (2) objective tests of anthropometry; mobility; lung function; dexterity; flexibility, strength and stability; hearing; balance; cognition and memory; foot sensation; and reaction time. Recruitment and testing processes were found to be feasible.Conclusion:This screening approach may provide new knowledge on healthy ageing in younger people.

show abstract

Section: Resultsmentioning

confidence: 99%

Feasibility of population screening tests to establish a healthy ageing trajectory

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Michigan Neuropathy Screening Questionnaire was applied and vibration sensation was tested in the great toe using a 128-Hz tuning fork, pressure sensation test with Semmes-Weinstein 10g monofilament and temperature sensation test with thermal sensitivity tester Tip Therm were used for neuropathy screening. Peripheral neuropathy was diagnosed when two or more of the tests were abnormal [16, 17]. …”

Section: Methodsmentioning

confidence: 99%

The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter?

et al. 2016

View full text Add to dashboard Cite

BackgroundInitial classification of diabetes of young may require revision to improve diagnostic accuracy of different forms of diabetes.The aim of our study was to examine markers of beta-cell autoimmunity in a cohort of young (0–25 years) patients with type 1 diabetes and compare the presentation and course of the disease according to the presence of pancreatic antibodies.MethodsCross-sectional population-based study was performed covering 100% of pediatric (n = 860) and 70% of 18–25 years old adult patients (n = 349) with type 1 diabetes in Lithuania.ResultsNo antibodies (GAD65, IA-2, IAA and ICA) were found in 87 (7.5%) cases. Familial history of diabetes was more frequent in those with antibodies-negative diabetes (24.1 vs. 9.4%, p < 0.001). Gestational age, birth weight and age at diagnosis was similar in both groups. Ketosis at presentation was more frequent in patients with autoimmune diabetes (88.1 vs. 73.5%, p < 0.05). HbA1c at the moment of investigation was 8.6 (3) vs. 8.7 (2.2)% in antibodies-negative and antibodies-positive diabetes groups, respectively, p > 0.05. In the whole cohort, neuropathy was found in 8.8% and nephropathy - in 8.1% of cases, not depending on autoimmunity status. Adjusted for age at onset, disease duration and HbA1c, retinopathy was more frequent in antibodies-negative subjects (13.8 vs. 7.8%, p < 0.05).ConclusionAntibodies-negative pediatric and young adult patients with type 1 diabetes in this study had higher incidence of family history of diabetes, higher frequency of retinopathy, less frequent ketosis at presentation, but similar age at onset, HbA1c, incidence of nephropathy and neuropathy compared to antibodies-positive patients.

show abstract

“…Participants wore their own athletic or walking shoes that passed a screen for excessive wear, fit (length and width), accommodation of bony deformities, and areas of high pressure. 22 Participants with footwear that did not meet the criteria were helped to select appropriately fitting shoes.…”

Section: Methodsmentioning

confidence: 99%

Weight-Bearing Versus Nonweight-Bearing Exercise for Persons With Diabetes and Peripheral Neuropathy: A Randomized Controlled Trial

Mueller

Tuttle

LeMaster

et al. 2013

Archives of Physical Medicine and Rehabilitation

112

138

View full text Add to dashboard Cite

Objective To determine the effects of weight-bearing (WB) versus nonweight-bearing (NWB) exercise for persons with diabetes mellitus (DM) and peripheral neuropathy (PN). Design Randomized controlled trial with evaluations at baseline and after intervention. Setting University-based physical therapy research clinic. Participants Participants with DM and PN (N=29) (mean age ± SD, 64.5±12.5y; mean body mass index [kg/m2] ± SD, 35.5±7.3) were randomly assigned to WB (n=15) and NWB (n=14) exercise groups. All participants (100%) completed the intervention and follow-up evaluations. Interventions Group-specific progressive balance, flexibility, strengthening, and aerobic exercise conducted sitting or lying (NWB) or standing and walking (WB) occurred 3 times a week for 12 weeks. Main Outcome Measures Measures included the 6-minute walk distance (6MWD) and daily step counts. Secondary outcome measures represented domains across the International Classification of Functioning, Disability and Health. Results The WB group showed greater gains than the NWB group over time on the 6MWD and average daily step count (P<.05). The mean and 95% confidence intervals (CIs) between-group difference over time was 29m (95% CI, 6–51) for the 6MWD and 1178 (95% CI, 150–2205) steps for the average daily step count. The NWB group showed greater improvements than the WB group over time in hemoglobin A1c values (P<.05). Conclusions The results of this study indicate the ability of this population with chronic disease to increase 6MWD and daily step count with a WB exercise program compared with an NWB exercise program.

show abstract

Reprint—Comprehensive Foot Examination and Risk Assessment: A Report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, With Endorsement by the American Association of Clinical Endocrinologists

Cited by 133 publications

References 0 publications

Feasibility of population screening tests to establish a healthy ageing trajectory

Feasibility of population screening tests to establish a healthy ageing trajectory

The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter?

Weight-Bearing Versus Nonweight-Bearing Exercise for Persons With Diabetes and Peripheral Neuropathy: A Randomized Controlled Trial

Contact Info

Product

Resources

About